fda import alert semaglutide tirzepatide green list Moves to Close a Compounded GLP-1 Loophole: What the 503B Proposal Means for Patients BREAKING NEWS: FDA has it’s

You feel fuller faster, reduce cravings, and eat lesswithout the constant battle of dieting

Unlike crash diets that lead to short-term weight loss, Semaglutide fosters a sustainable approach to wellness and weight management that can support you in the long run

These include cold and flu symptoms, signs of hypoglycemia, abdominal pain, nausea, vomiting, constipation, diarrhea, fatigue and allergic and adverse reactions

Weight regain is common after stopping semaglutide if lifestyle changes are not maintained

BMJ (Clin Res Ed) 2000;321(7258): 412419

The FDA removed semaglutide from its shortage list in March 2025, ending the legal basis for most compounded semaglutide